These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35855840)

  • 21. [Expression and clinical significance of GRHL2 in colorectal cancer].
    Quan Y; Xu M; Cui P; Ye M; Zhuang B; Min Z
    Zhonghua Zhong Liu Za Zhi; 2015 Oct; 37(10):764-8. PubMed ID: 26813596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circ_0111277 suppresses trophoblast cell proliferation, angiogenesis, migration, invasion and EMT via regulating miR-188-3p/GRHL2 axis.
    Zhou M; Yu X; Li C; Lou L; Yang S; Cai J; Cai C
    Am J Reprod Immunol; 2023 Mar; 89(3):e13657. PubMed ID: 36409529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Azacitidine induces demethylation of p16INK4a and inhibits growth in adult T-cell leukemia/lymphoma.
    Uenogawa K; Hatta Y; Arima N; Hayakawa S; Sawada U; Aizawa S; Yamamoto T; Takeuchi J
    Int J Mol Med; 2011 Nov; 28(5):835-9. PubMed ID: 21785817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The promoter of miR-663 is hypermethylated in Chinese pediatric acute myeloid leukemia (AML).
    Yan-Fang T; Jian N; Jun L; Na W; Pei-Fang X; Wen-Li Z; Dong W; Li P; Jian W; Xing F; Jian P
    BMC Med Genet; 2013 Jul; 14():74. PubMed ID: 23870168
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The oligodendrocyte lineage transcription factor 2 (OLIG2) is epigenetically regulated in acute myeloid leukemia.
    Yalcin A; Kovarbasic M; Wehrle J; Claus R; Becker H; Abdelkarim M; Gaidzik VI; Schmidts A; Wäsch R; Pahl HL; Döhner K; Bullinger L; Duyster J; Lübbert M; Hackanson B
    Exp Hematol; 2017 Nov; 55():76-85.e3. PubMed ID: 28760688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypermethylation of the GATA binding protein 4 (GATA4) promoter in Chinese pediatric acute myeloid leukemia.
    Tao YF; Fang F; Hu SY; Lu J; Cao L; Zhao WL; Xiao PF; Li ZH; Wang NN; Xu LX; Du XJ; Sun LC; Li YH; Li YP; Xu YY; Ni J; Wang J; Feng X; Pan J
    BMC Cancer; 2015 Oct; 15():756. PubMed ID: 26490736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Promoter hypermethylation of FBXO32, a novel TGF-beta/SMAD4 target gene and tumor suppressor, is associated with poor prognosis in human ovarian cancer.
    Chou JL; Su HY; Chen LY; Liao YP; Hartman-Frey C; Lai YH; Yang HW; Deatherage DE; Kuo CT; Huang YW; Yan PS; Hsiao SH; Tai CK; Lin HJ; Davuluri RV; Chao TK; Nephew KP; Huang TH; Lai HC; Chan MW
    Lab Invest; 2010 Mar; 90(3):414-25. PubMed ID: 20065949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The transcription factors Grainyhead-like 2 and NK2-homeobox 1 form a regulatory loop that coordinates lung epithelial cell morphogenesis and differentiation.
    Varma S; Cao Y; Tagne JB; Lakshminarayanan M; Li J; Friedman TB; Morell RJ; Warburton D; Kotton DN; Ramirez MI
    J Biol Chem; 2012 Oct; 287(44):37282-95. PubMed ID: 22955271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Relationship between RAR-beta gene expression defect and its methylation].
    Gao YP; Li M; Zhang YY; Wang H; He XH; Wang ZH
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jul; 42(7):472-6. PubMed ID: 17961338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of transcription factor grainyhead-like 2 is diminished in cervical cancer.
    Torres-Reyes LA; Alvarado-Ruiz L; Piña-Sánchez P; Martínez-Silva MG; Ramos-Solano M; Olimón-Andalón V; Ortiz-Lazareno PC; Hernández-Flores G; Bravo-Cuellar A; Aguilar-Lemarroy A; Jave-Suarez LF
    Int J Clin Exp Pathol; 2014; 7(11):7409-18. PubMed ID: 25550776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The 5' flanking region of miR-378 is hypomethylated in acute myeloid leukemia.
    Zhu XW; Wen XM; Zhang YY; Yang L; Guo H; Yang J; Zhang M; Yin JY; Ma JC; Lin J; Deng ZQ; Qian J
    Int J Clin Exp Pathol; 2015; 8(5):4321-31. PubMed ID: 26191124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Azacytidine sensitizes acute myeloid leukemia cells to arsenic trioxide by up-regulating the arsenic transporter aquaglyceroporin 9.
    Chau D; Ng K; Chan TS; Cheng YY; Fong B; Tam S; Kwong YL; Tse E
    J Hematol Oncol; 2015 May; 8():46. PubMed ID: 25953102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Methylation and demethylation of SOX2 gene promoter in BGC-823 gastric cancer cells].
    Wei B; Liu G; Cai HL; Li GP; Huang HQ; Luo Q; Huang ZJ
    Zhonghua Yi Xue Za Zhi; 2016 Aug; 96(32):2548-53. PubMed ID: 27596549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Inactivation of PMS2 gene by promoter methylation in nasopharyngeal carcinoma].
    Ni HF; Jiang B; Zhou Z; Li Y; Yuan XY; Cao XL; Huang GW
    Zhonghua Zhong Liu Za Zhi; 2016 Nov; 38(11):812-817. PubMed ID: 27998438
    [No Abstract]   [Full Text] [Related]  

  • 35. Epigenetic inactivation of the MIR129-2 in hematological malignancies.
    Wong KY; Yim RL; Kwong YL; Leung CY; Hui PK; Cheung F; Liang R; Jin DY; Chim CS
    J Hematol Oncol; 2013 Feb; 6():16. PubMed ID: 23406679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methylation-associated dysregulation of the suppressor of cytokine signaling-3 gene in multiple myeloma.
    Wilop S; van Gemmeren TB; Lentjes MH; van Engeland M; Herman JG; Brümmendorf TH; Jost E; Galm O
    Epigenetics; 2011 Aug; 6(8):1047-52. PubMed ID: 21934357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aberrant SOX11 promoter methylation is associated with poor prognosis in gastric cancer.
    Xu X; Chang X; Li Z; Wang J; Deng P; Zhu X; Liu J; Zhang C; Chen S; Dai D
    Cell Oncol (Dordr); 2015 Jun; 38(3):183-94. PubMed ID: 25801783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GRHL2 inhibits colorectal cancer progression and metastasis via oppressing epithelial-mesenchymal transition.
    Yang Z; Wu D; Chen Y; Min Z; Quan Y
    Cancer Biol Ther; 2019; 20(9):1195-1205. PubMed ID: 31063022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GRHL2 Upregulation Predicts a Poor Prognosis and Promotes the Resistance of Serous Ovarian Cancer to Cisplatin.
    Nie Y; Ding Y; Yang M
    Onco Targets Ther; 2020; 13():6303-6314. PubMed ID: 32636649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methylation-independent ITGA2 overexpression is associated with poor prognosis in de novo acute myeloid leukemia.
    Lian XY; Zhang W; Wu DH; Ma JC; Zhou JD; Zhang ZH; Wen XM; Xu ZJ; Lin J; Qian J
    J Cell Physiol; 2018 Dec; 233(12):9584-9593. PubMed ID: 30132837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.